EXICURE, INC. Tax Withholding Paid on Stock Awards
EXICURE, INC. (XCUR) reported Tax Withholding Paid on Stock Awards of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2025-03-18
- EXICURE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- EXICURE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $123.00K, a 2975.00% increase from fiscal 2022.
- EXICURE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $4.00K, a 71.43% decline from fiscal 2021.
- EXICURE, INC. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $14.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $0.00 10-K · filed 2025-03-18 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $1.00K derived: sum of 4 quarters · filed 2025-03-18 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $1.00K derived: sum of 3 quarters · filed 2025-03-18 | $2.00K derived: sum of 4 quarters · filed 2025-03-18 |
| 2024-03-31 | $0.00 10-Q · filed 2024-06-17 | $1.00K derived: sum of 2 quarters · filed 2025-03-18 | $2.00K derived: sum of 3 quarters · filed 2025-03-18 | $121.00K derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $2.00K derived: sum of 2 quarters · filed 2025-03-18 | $121.00K derived: sum of 3 quarters · filed 2025-03-18 | $123.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $120.00K derived: sum of 2 quarters · filed 2024-11-14 | $122.00K 10-Q · filed 2024-11-14 | $122.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $121.00K 10-Q · filed 2024-08-13 | $121.00K derived: sum of 3 quarters · filed 2024-08-13 | $123.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $2.00K 10-Q · filed 2024-06-17 | $2.00K derived: sum of 2 quarters · filed 2024-06-17 | $4.00K derived: sum of 3 quarters · filed 2024-06-17 | $5.00K derived: sum of 4 quarters · filed 2024-06-17 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $2.00K derived: sum of 2 quarters · filed 2024-06-06 | $3.00K derived: sum of 3 quarters · filed 2024-06-06 | $4.00K 10-K · filed 2024-06-06 |
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $3.00K derived: sum of 2 quarters · filed 2024-06-06 | $4.00K 10-Q · filed 2024-05-16 | $9.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | $1.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | $2.00K 10-Q/A · filed 2024-06-06 | $7.00K derived: sum of 3 quarters · filed 2024-06-06 | $16.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | $1.00K 10-Q/A · filed 2024-06-06 | $6.00K derived: sum of 2 quarters · filed 2024-06-06 | $15.00K derived: sum of 3 quarters · filed 2024-06-06 | $15.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $14.00K derived: sum of 2 quarters · filed 2023-03-27 | $14.00K derived: sum of 3 quarters · filed 2023-03-27 | $14.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $9.00K derived: sum of 2 quarters · filed 2022-11-14 | $9.00K 10-Q · filed 2022-11-14 | $9.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | $0.00 derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $0.00 10-K · filed 2022-03-25 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |